XRCC1 and ovarian cancer: In a study by Abdel-Fatah et al., siRNA-mediated knockdown of XRCC1 in OVCAR-3 and OVCAR-4 human ovarian cancer cells resulted in greater platinum sensitivity, demonstrating XRCC1’s active involvement in platinum resistance in ovarian cancer [180].